홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tert-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate → 5-amino-N-(4-(3-aminopiperidin-1-yl)pyridin-3-yl)-2-(piperidin-3-yl)thiazole-4-carboxamide

HRID 2088441
인쇄

반응식

HRID 2088441 반응식
[NH2:1][C:2]1[CH:3]=[N:4][CH:5]=[CH:6][C:7]=1[N:8]1[CH2:13][CH2:12][CH2:11][CH:10]([NH:14]C(=O)OC(C)(C)C)[CH2:9]1.C(OC([N:29]1[CH2:34][CH2:33][CH2:32][CH:31]([C:35]2[S:36][C:37]([NH:43]C(OC(C)(C)C)=O)=[C:38]([C:40](O)=[O:41])[N:39]=2)[CH2:30]1)=O)(C)(C)C>>[NH2:43][C:37]1[S:36][C:35]([CH:31]2[CH2:32][CH2:33][CH2:34][NH:29][CH2:30]2)=[N:39][C:38]=1[C:40]([NH:1][C:2]1[CH:3]=[N:4][CH:5]=[CH:6][C:7]=1[N:8]1[CH2:13][CH2:12][CH2:11][CH:10]([NH2:14])[CH2:9]1)=[O:41]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 67130164Tert-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamateHCID 698122382-(1-(Tert-butoxycarbonyl)piperidin-3-yl)-5-(tert-butoxycarbonylamino)thiazole-4-carboxylic acid

생성물 1

HCID 510021985-amino-N-(4-(3-aminopiperidin-1-yl)pyridin-3-yl)-2-(piperidin-3-yl)thiazole-4-carboxamide수율 51%

실험 절차

Followed the procedure as described in EXAMPLE 1, starting with tert-butyl 1-(3-aminopyridin-4-yl)piperidin-3-ylcarbamate and 2-(1-(tert-butoxycarbonyl)piperidin-3-yl)-5-(tert-butoxycarbonylamino)thiazole-4-carboxylic acid. Obtained the desired product as a white solid (6.4 mg, 51%). 1H NMR (500 MHz, DMSO) δ 9.38 (s, 1H), 8.37 (s, 1H), 8.19 (d, J=5.1 Hz, 1H), 7.28 (s, 2H), 7.11 (d, J=5.1 Hz, 1H), 3.14 (dd, J=28.4, 11.4 Hz, 2H), 2.94 (dd, J=51.3, 24.0 Hz, 4H), 2.65 (dd, J=27.1, 13.0 Hz, 2H), 2.50-2.40 (m, 1H), 2.05 (s, 1H), 1.97-1.56 (m, 5H), 1.47 (d, J=11.2 Hz, 1H), 1.24 (d, J=8.3 Hz, 2H). ESIMS m/z=402.1 (M+1).

출처 및 근거

ORD 기록
ord-b8f484f13dc24125923af8edcfc26470
출처 데이터셋
uspto-grants-2013_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08435976B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트